1. A method for the treatment or reduction of myocardial injury area of the subject being revascularization after an acute myocardial infarction due to natural pathological process, wherein the method comprises the steps of: (a) parenterally administering to the subject through a catheter sterile pharmaceutical composition comprising: (i) improving perfusion infarct region number selected non-swelling sterile chemotactic product of hematopoietic stem cells as a first therapeutic agent, which improves erfuziyu in myocardial number chemotactic product of hematopoietic stem cells comprises enriched population of isolated autologous CD34 + hematopoietic stem cells comprising the subpopulation of highly CD34 + cells expressing CXCR-4 and having a CXCR-4-mediated chemotactic activity, which enriched population of isolated autologous CD34 + hematopoietic stem cells provides at least, 0,5 × 10vysokoaktivnyh CD34 + cells expressing CXCR-4 and having CXCR-4 mediated hemotak matic activity (ii) a stabilizing amount of serum, wherein a stabilizing amount of serum is more than 20% (.. v / v), and (iii) optionally a therapeutically effective amount of at least one compatible second therapeutic agent and (b) improve perfusion in at least one region of myocardial relative to control cases where at least 70% of the cells in the enriched population of selected CD34 + cells comprising the subpopulation of highly active cells, which express CXCR-4, and which have CXCR- 4
